BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7123673)

  • 1. Tamoxifen therapy in advanced breast cancer with positive estrogen receptors in postmenopausal women.
    Bono A; Fariselli G; Bettoni I; Alloisio M; Nicoli N; Di Pietro S
    Tumori; 1982 Apr; 68(2):143-7. PubMed ID: 7123673
    [No Abstract]   [Full Text] [Related]  

  • 2. Tamoxifen therapy, oestrogen receptor status, and postmenopausal breast cancer.
    A'Hern RP; Wilson AJ; Baum M
    Lancet; 1985 Apr; 1(8435):976. PubMed ID: 2859424
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tamoxifen therapy in locally advanced primary and recurrent breast cancer (author's transl)].
    Wada T; Koyama H; Takahashi Y; Nishizawa Y; Iwanaga T; Aoki Y; Terasawa T
    Nihon Gan Chiryo Gakkai Shi; 1979 Aug; 14(5):819-24. PubMed ID: 501187
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic effect of tamoxifen versus combined tamoxifen and diethylstilboestrol in advanced breast cancer in postmenopausal women.
    Mouridsen HT; Salimtschik M; Dombernowsky P; Gelshoj K; Palshof T; Rorth M; Daehnfeldt JL; Rose C
    Eur J Cancer (1965); 1980; Suppl 1():107-10. PubMed ID: 7032918
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant tamoxifen in postmenopausal breast cancer: preliminary results of a randomized trial.
    Delozier T; Julien JP; Juret P; Veyret C; Couëtte JE; Graic Y; Ollivier JM; de Ranieri E
    Breast Cancer Res Treat; 1986; 7(2):105-9. PubMed ID: 3521767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients.
    Morgan LR
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):43-7. PubMed ID: 3975652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values.
    Rose C; Thorpe SM; Andersen KW; Pedersen BV; Mouridsen HT; Blichert-Toft M; Rasmussen BB
    Lancet; 1985 Jan; 1(8419):16-9. PubMed ID: 2856949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II experience with toremifene in the treatment of ER-positive breast cancer of postmenopausal women.
    Valavaara R
    Cancer Invest; 1990; 8(2):275-6. PubMed ID: 2144787
    [No Abstract]   [Full Text] [Related]  

  • 9. Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.
    Gelber RD
    Recent Results Cancer Res; 1984; 96():102-9. PubMed ID: 6396763
    [No Abstract]   [Full Text] [Related]  

  • 10. Tamoxifen efficacy in advanced breast cancer previously treated with endocrine and cytotoxic therapy.
    De Lena M; Brambilla C; Jirillo A
    Tumori; 1980 Jun; 66(3):339-48. PubMed ID: 7445113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen and combination chemotherapy as adjuvant treatment in postmenopausal women with breast cancer.
    Wallgren A; Baral E; Beling U; Carstensen J; Friberg S; Glas U; Kaigas M; Skoog L
    Recent Results Cancer Res; 1984; 96():197-203. PubMed ID: 6396775
    [No Abstract]   [Full Text] [Related]  

  • 12. Principles and indications of endocrine treatment of advanced breast cancer.
    Mouridsen HT; Palshof T
    Recent Results Cancer Res; 1980; 71():112-7. PubMed ID: 7367722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of estrogen dependency of human breast cancers. II. Clinical evaluation of tamoxifen in advanced primary and recurrent breast cancer.
    Nishiki M; Yamane M; Amano K; Yasuda K; Okumichi T; Ezaki H
    Hiroshima J Med Sci; 1984 Jun; 33(2):163-6. PubMed ID: 6480380
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-estrogen therapy for breast cancer: focus on tamoxifen.
    Flynn KT; Durivage HJ
    Oncol Nurs Forum; 1982; 9(4):21-5. PubMed ID: 6923414
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of adjuvant endocrine therapy in primary breast cancer.
    Baum M; Ebbs SR
    Recent Results Cancer Res; 1989; 115():136-43. PubMed ID: 2696026
    [No Abstract]   [Full Text] [Related]  

  • 16. The management of locally advanced carcinoma of the breast by Nolvadex (tamoxifen): a pilot study.
    Campbell FC; Morgan DA; Bishop HM; Benton FM; Blamey RW; Elston CW; Nicholson RI; Griffiths K
    Clin Oncol; 1984 Jun; 10(2):111-5. PubMed ID: 6734002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medroxyprogesterone acetate versus tamoxifen in the therapy of advanced breast cancer.
    Lorenz I; Mechl Z
    Neoplasma; 1985; 32(1):119-24. PubMed ID: 3157070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen (antiestrogen) therapy in advanced breast cancer.
    Kiang DT; Kennedy BJ
    Ann Intern Med; 1977 Dec; 87(6):687-90. PubMed ID: 931204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant tamoxifen treatment of elderly women with stage II breast cancer. A double-blind comparison with placebo.
    Cummings FJ; Gray R; Davis TE; Tormey DC; Harris JE; Falkson G; Arseneau J
    Ann Intern Med; 1985 Sep; 103(3):324-9. PubMed ID: 3896085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tamoxifen-induced progesterone receptors in breast tumors].
    Tsyrlina EV; Semiglazov VF; Nurgaziev KSh; Ivanova OA
    Vopr Onkol; 1991; 37(9-10):916-21. PubMed ID: 1842650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.